Exploring the Influence of Trptophan on the Treatment of Pouchitis

ConditionPouchitis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitätsklinikum Hamburg-Eppendorf

About this trial

Patients with a pouch frequently suffer from chronic inflammation of the intestinal tract, called pouchitis. Pouchitis is routienly treated with repeated courses of antibiotics and probiotics, which does not stop the inflammation from recurring and exposes the patients to the risk of developing antibiotic -resistant pouchitis. Experimental data suggest that the effectiveness of the antibiotic and probiotic treatment can be prolonged by high consumption of trypotophan, an aminoacid present in everyday food. The Try Pro Pouch study aims to compare the consumption of high amounts of tryptophan against placebo in patients with pouchitis.

Eligibility criteria

Qualifiers

Pouchitis (PDAI >= 7)

indication for the application of antibiotics and probiotics

Age >=18 years

Informed consent

Disqualifiers

major surgery planned druing the intervention

high risk for malnutrition (NRS 2002 >=3/ BMI <18,5 kg/m²)

Trial design

Treatments tested in this trial

  • Tryptophan 25mg/kg bodyweight
  • Placebo

Treatment groups

20 Participants
are divided into 2 treatment groups

Locations

This trial has no locations